Michael Stowell

Michael is a professor at the University of Colorado, Boulder in the Department of Molecular, Cellular, and Developmental Biology. He is a biophysicist with expertise in the structural biology of channels and receptors. He is a co-founder of InRedox and a co-founder and CSO of AmideBio. Michael joined the BioLoomics Scientific Advisory Board in 2021 and helps guide the decisions in performing targeted saturation mutagenesis of protein drugs to enhance specificity and efficacy.